Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Launches Generic Version of Soma® Compound With Aspirin Tablets and Sodium Bicarbonate Tablets

Published: Jul 09, 2012

PORT WASHINGTON, N.Y., July 9, 2012 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical active ingredients and intermediates, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generics subsidiary, has launched the 200mg/325mg strengths of Carisoprodol and Aspirin Tablets, USP, an FDA approved generic version of Meda Pharmaceutical's Soma® Compound with Aspirin Tablets, and 10/gr Sodium Bicarbonate Tablets, USP. According to IMS Health data, U.S. market sales for Carisoprodol and Aspirin Tablets, USP, used to relieve pain, muscle spasm and limited mobility associated with acute painful musculoskeletal conditions, and Sodium Bicarbonate Tablets, USP, an antacid used to relieve heartburn and acid indigestion, were approximately $3.1 million collectively for the twelve months ended December 31, 2011.

Back to news